Meredith Emmerich
First SEC filing: March 6, 2026 · Latest: March 6, 2026
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| March 5, 2026 | XYL | F | 158 | $126.19 | $19,938 | 5,447 Direct | -2.82% | Disposed | -18.8% (price as of 2026-10-05) |
| March 2, 2026 | XYL | A | 1,610 | · | · | 5,605 Direct | +40.30% | Acquired | (price as of 2026-10-05) |
| March 2, 2026 | XYL | A | 5,739 | $128.98 | $740,216 | 5,739 Direct | · | Acquired | -20.6% (price as of 2026-10-05) |
| Oct. 21, 2025 | XYL | F | 841 | $147.19 | $123,787 | 3,992 Direct | -17.40% | Disposed | -30.4% (price as of 2026-10-05) |
| March 5, 2025 | XYL | A | 1,060 | $129.67 | $137,450 | 4,833 Direct | +28.09% | Acquired | -21.0% (price as of 2026-10-05) |
| March 5, 2025 | XYL | A | 3,721 | $129.67 | $482,502 | 3,721 Direct | · | Acquired | -21.0% (price as of 2026-10-05) |
| Oct. 21, 2024 | XYL | A | 3,772 | $132.54 | $499,941 | 3,772 Direct | · | Acquired | -22.7% (price as of 2026-10-05) |
| Oct. 21, 2024 | XYL | A | 33,138 | $132.54 | $4,392,111 | 33,138 Direct | · | Acquired | -22.7% (price as of 2026-10-05) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| March 2, 2026 | XYL | Non-Qualified Stock Options (Right to Buy) | Common Stock | $128.98 | March 2, 2036 | 5,739 | Acquired |
| March 5, 2025 | XYL | Non-Qualified Stock Options (Right to buy) | Common Stock | $129.67 | March 5, 2035 | 3,721 | Acquired |
| Oct. 21, 2024 | XYL | Stock Options (Right to buy) | Common Stock | $132.54 | Oct. 21, 2034 | 33,138 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2024 | $80,481 | $1,050,000 | · | · | · | · | $2,414 | $2,932,897 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.